EMA/PE/0000181219 - paediatric investigation plan

bedaquiline fumarate

Key facts

• Invented name:
  • Sirturo
  • Sirturo
• Active substance:
  bedaquiline fumarate
• Therapeutic area:
  Infectious diseases
• Decision number:
  P/0470/2022
• PIP number:
  EMA/PE/0000181219
• Pharmaceutical form(s):
  • Tablet
  • Granules
• Condition(s) / indication(s):
  Treatment of multi-drug-resistant tuberculosis
• Route(s) of administration:
  Oral use
• Decision type:
  PM: decision on the application for modification of an agreed PIP
• Decision date:
  06/12/2024
• Compliance check done:
  Nu

Decision

EMA/PE/0000181219: EMA decision of 6 December 2024 on the acceptance of a modification of an agreed paediatric investigation plan for bedaquiline (fumarate) (Sirturo)

Adopted Reference Number: EMADOC-1700519818-1775423